Placental vascular development (angiogenesis) is critical for placental function and thus for normal embryonic/fetal growth and development. Specific environmental factors or use of assisted reproductive techniques may result in poor placental angiogenesis, which may contribute to embryonic losses and/or fetal growth retardation. Uterine tissues were collected on days 14, 16, 18, 20, 22, 24, 26, 28, and 30 after mating and on day 10 after estrus (nonpregnant controls) to determine vascular development and expression of several factors involved in the regulation of angiogenesis in the endometrium. Compared with controls, several measurements of endometrial vascularity increased (P!0.001) including vascular labeling index (LI; proportion of proliferating cells), the tissue area occupied by capillaries, area per capillary (capillary size), total capillary circumference per unit of tissue area, and expression of factor VIII (marker of endothelial cells), but capillary number decreased (P!0.001). Compared with controls, mRNA for placental growth factor, vascular endothelial growth factor receptors, angiopoietins (ANGPT) 1 and 2, ANGPT receptor TEK, endothelial nitric oxide synthase, and hypoxia-inducible factor 1a increased (P!0.05) during early pregnancy. Vascular LI was positively correlated (P!0.05) with several measurements of vascularity and with mRNA expression of angiogenic factors. These data indicate that endometrial angiogenesis, manifested by increased vascularity and increased expression of several factors involved in the regulation of angiogenesis, is initiated very early in pregnancy. This more complete description of early placental angiogenesis may provide the foundation for determining whether placental vascular development is altered in compromised pregnancies.
Introduction
During pregnancy, vascular development or angiogenesis parallels the growth of uterine and placental tissues to support fetal growth and development (Reynolds & Redmer 2001 , Reynolds et al. 2005a , 2005b , 2005c . Inadequate vascular growth during early pregnancy may be associated with inadequate uterine and umbilical blood flow, which directly affects transport of nutrients to the embryo/fetus. The consequences of inadequate placental vascular development include compromised implantation, spontaneous abortion/ embryonic loss, defective formation of the placenta, and altered fetal growth and development resulting in intrauterine growth restriction potentially leading to reduced lifelong health and productivity of the offspring (Sherer & Abulafia 2001 , Wallace et al. 2002 , Torry et al. 2004 , Reynolds et al. 2005a , 2005b , 2005c , 2010 , Demir et al. 2007 .
In mammals, most of the embryonic loss occurs in early pregnancy reaching R30% of embryos lost in most species and possibly R50% in humans (Reynolds & Redmer 2001) . These are astonishing figures, and highlight the early part of pregnancy as a critical period of pregnancy, which is not surprising as this is the time during which embryonic organogenesis occurs and the placenta is established (Reynolds et al. 2010) . High embryonic loss may appear as a consequence of a variety of negative effects, and thus establishes the need to analyze angiogenesis in both normal and compromised pregnancies, such as those generated from assisted reproductive technologies, or affected by environmental factors such as malnutrition or other factors leading to stress.
Angiogenesis is the formation of new blood vessels from pre-existing vasculature, and it is a critical process for the growth and development of all tissues, including the placenta (Reynolds & Redmer 1992 , 1998 , Borowicz et al. 2007 , Reynolds et al. 2010 . Growth of the tissue is associated with the high metabolic demands (Reynolds & Redmer 1998) . The placenta, which serves as the organ of exchange between maternal and fetal systems, represents a very fast growing tissue with a high metabolic demand that requires a dynamic angiogenic process from early to late pregnancy to support its growth and function (Reynolds & Redmer 1995 , Mayhew 2002 , Redmer et al. 2004 , Torry et al. 2004 , Reynolds et al. 2005a , 2005b , 2005c , 2010 . Angiogenesis is regulated by numerous angiogenic and other factors including vascular endothelial growth factor (VEGF) family, fibroblast growth factor 2 (FGF2, also known as basic FGF), angiopoietins (ANGPT), nitric oxide (NO), and other systems (Reynolds & Redmer 1998 , Reynolds et al. 2005a , 2005b , 2005c , 2010 . Moreover, in compromised pregnancies (that is, pregnancies in which fetal or placental growth, or both, is affected), placental angiogenesis is also abnormal at mid to late periods , Reynolds et al. 2005a , 2005b , 2005c , 2010 , Burton et al. 2009 ). Although the importance of vasculogenesis and angiogenesis during early pregnancy is well recognized (Pfarrer et al. 2001 , Sherer & Abulafia 2001 , Mayhew 2002 , Demir et al. 2007 , Reynolds et al. 2010 , limited data are available concerning the timing of initiation of placental angiogenesis, changes in vascular development and expression of angiogenic factors during this period. Previously, we have reported changes in vascular growth during early pregnancy in sheep (Reynolds & Redmer 1992 , Zheng et al. 1996 ; however, relatively few days were studied, and therefore, we recognized the need for a more detailed analysis as in the present study.
We hypothesized that proliferation of vascular cells, vascular growth, and expression of several angiogenic factors and their receptors, and factors involved in the regulation of angiogenesis will begin to change very early in pregnancy, and that these processes will be interrelated. Therefore, the purpose of the present study was to determine 1) the pattern of vascular cell proliferation, vascular growth, and mRNA expression of several angiogenic factors and factors involved in the regulation of angiogenesis including placental growth factor (PGF), VEGF and their receptors FLT1 and KDR, FGF2 and its receptor FGFR2IIIc, ANGPT1 and -2 and their receptor TEK, endothelial NO synthase (NOS3) and NO receptor soluble guanylate cyclase (GUCY1B3), and hypoxia-inducible factor 1a (HIF1A) in the uterine endometrium (maternal placenta) during early pregnancy, and 2) the correlative relationship(s) among these factors. These data will serve as an important reference for future studies of defects in angiogenesis in compromised pregnancies.
Results
Proliferating cells marked by proliferating cell nuclear antigen (PCNA; Fig. 1 ), and the network of blood vessels marked by hematoxylin and periodic acid-Schiff's reagent (H plus PAS) staining (Fig. 1) or factor VIII (marker of endothelial cells and thus vascularization; Fig. 2 ) were localized in caruncular (CAR) and intercaruncular (ICAR) regions of endometrial tissues in nonpregnant (NP) and pregnant animals. By day 18 after mating, the endometrial luminal epithelium was beginning to flatten, becoming low cuboidal to squamous (Fig. 1C) , compared with that observed on earlier days of pregnancy (days 14 and 16), when they were primarily columnar ( Fig. 1A and B ). In addition, by day 18, the subepithelial capillary plexus, which we have previously described (Reynolds & Redmer 1992 , Reynolds et al. 2005a , was beginning to form (Fig. 1C, inset) , and by day 28, it was quite well developed (Fig. 1E, inset) . Extensive vascularization of the endometrial CAR and ICAR tissues began as early as day 18, and was extensive by day 28 after mating ( Fig. 1C-E) . In addition, in some of the ewes, microscopic fetal and maternal placental villi were evident by day 30, and were beginning to vascularize (Fig. 1F ). In contrast, on days 14 and 16 after mating ( Fig. 1A and B respectively), these pregnancy-induced changes in endometrial morphology or vascular development were not yet evident.
The pattern of changes in vascularity and vascular development was similar in CAR and ICAR; therefore, data for vascular measurements including labeling index (LI; proportion of proliferating cells within blood vessel), capillary area density (CAD; total area occupied by capillaries expressed as a proportion per unit of tissue area), capillary number density (CND; total number of capillaries per unit of tissue area), capillary surface density (CSD; total capillary circumference per unit of tissue area), and area per capillary (APC; average crosssectional APC, which represents average capillary size) were combined for CAR and ICAR. Several measurements of vascular growth in CAR and ICAR areas including LI in the blood vessel (Fig. 3A) , CAD (Fig. 3B) , CND (Fig. 3C) , CSD (Fig. 3D) , APC (Fig. 3E) , and expression of factor VIII (Fig. 3F ) changed dramatically (P!0.0001-0.05) compared with day 10 of the estrous cycle (NP controls) or from day 14 to 30 of pregnancy. Compared with NP controls, vascular LI increased (P!0.0001) 7-to 20-fold on days 14-20, and 23-to 34-fold on days 22-30 of pregnancy (Fig. 3A) ; CAD increased (P!0.001) 1.3-fold on day 16 and 1.5-to 1.9-fold on days 20-30 (Fig. 3B) ; CND remained unchanged on days 14-20, and then decreased (P!0.0001) on days 22-30 of pregnancy (Fig. 3C) ; CSD increased (P!0.0001) 1.4-to 1.6-fold on days 20-30 of pregnancy (Fig. 3D) ; and APC increased (P!0.0001) 1.5-fold on days 16 and 22, and 2.2-to 3-fold on days 22-30 of pregnancy (Fig. 3E) .
Factor VIII was immunodetected in the endothelium of blood vessels in CAR and ICAR areas of endometrium throughout early pregnancy (Fig. 2) . The network of blood vessels in the endometrium on day 30 of pregnancy appears to be denser than in NP controls (Fig. 2) . Compared with NP controls, expression of factor VIII increased (P!0.001) two-to threefold on days 26-30 of pregnancy (Fig. 3F) .
LI was positively correlated with CAD (r 2 Z0.454; P!0.002), APC (r 2 Z0.577; P!0.0001), and expression of factor VIII (r 2 Z0.486; P!0.001), and negatively correlated with CND (r 2 ZK0.472; P!0.001). Compared with NP controls, expression of mRNAs for PGF, FLT1, KDR, FGFR2IIIc, ANGPT1, ANGPT2, TEK, NOS3, and HIF1A ( Fig. 4A-H ) in CAR tissues also changed dramatically (P!0.0002-0.03) during early pregnancy but for VEGF, FGF2, and GUCY13B mRNA remained unchanged (data not shown). Values for the expression of each mRNA were compared with NP controls. Expression of mRNA for PGF increased (P!0.0001) fivefold on day 24, and eight-to tenfold on days 26-30 of pregnancy (Fig. 4A) . Expression of mRNA for FLT1 increased (P!0.0003) 2-to 2.5-fold on days 20-28 and 3.8-fold on day 30 of pregnancy ( Fig. 4B) . Expression of mRNA for KDR increased (P!0.0002) 1.8-to 2.6-fold on days 18-30 of pregnancy (Fig. 4C) . Expression of mRNA for FGFR2IIIc increased (P!0.03) 1.5-fold on day 16 of pregnancy (data not shown) but not on any other day of pregnancy. Expression of mRNA for ANGPT1 increased (P!0.001) 2.1-to 2.5-fold on days 26-30 of pregnancy (Fig. 4D) . Expression of mRNA for ANGPT2 was similar from day 14 to 28, but increased (P!0.02) 2.4-fold on day 30 of pregnancy ( Fig. 4E) . Expression of mRNA for TEK increased (P!0.03) 1.8-to 2.3-fold on days 16-30 of pregnancy (Fig. 4F) . Expression of mRNA for NOS3 increased (P!0.001) 2.5-to 4.1-fold on days 18-30 of pregnancy (Fig. 4G) . Expression of mRNA for HIF1A increased (P!0.05) 2.2-to 3-fold on days 16-20 of pregnancy and then decreased to control level (Fig. 4H) .
For CAR tissues, a positive correlation was observed between LI and expression mRNAs for PGF (r 2 Z0.505; P!0.001), FLT1 (r 2 Z0.494; P!0.001), KDR (r 2 Z0.348; P!0.03), NOS3 (r 2 Z0.386; P!0.01), and HIF1A (r 2 Z0.388; P!0.01). CAD was positively correlated with mRNA expression of ANGPT1 (r 2 Z0.413; P!0.004) and tended to be positively correlated with mRNA expression of PGF (r 2 Z0.261; , and 30 (F) after mating. Note how immunohistochemical staining for PCNA (brownish nuclei; e.g. short arrows in E, inset) begins to appear on day 18 (C) and continues to increase through day 30 (F; bluish nuclei indicate hematoxylin staining). Also note the extensive vascularization of the endometrial caruncular (CAR) and intercaruncular (ICAR) tissues beginning on day 18 (C) and continuing through day 28 (E; in C-E, the arrows indicate some of the developing larger and smaller microvessels). By day 18, a subepithelial capillary plexus, which we have previously described (Reynolds & Redmer 1992 , Reynolds et al. 2005a , was beginning to form (C, inset, arrowhead; note the two endothelial nuclei in this capillary), and by day 28, it was quite well developed (E, inset, arrowheads); in C and E, the small dashed boxes indicate the location from which the insets were taken. Additionally, by day 30, microscopic fetal and maternal placental villi (F; large arrowhead and large arrow respectively) were evident and were beginning to vascularize (F, arrows). Also note the numerous capillaries in longitudinal section on day 30 (asterisks in lower right of F). In contrast, on days 14 and 16 after mating (A and B respectively), these pregnancyinduced changes in endometrial morphology and vascular development were not yet evident. Vascular architecture for day 20 was similar to day 18, and for day 22 was similar to day 24 of pregnancy; therefore, micrographs representing days 20 and 22 of pregnancy are not shown. Bar in AZ100 mm, and FM, fetal membranes.
Angiogenesis during maternal placental development 167 www.reproduction-online.org Reproduction (2010) 140 165-174 P!0.07). APC was positively correlated with mRNA expression of PGF (r 2 Z0.440; P!0.002) and ANGPT1 (r 2 Z0.472; P!0.001), and tended to be positively correlated with mRNA expression of FLT1 (r 2 Z0.227; P!0.08) and NOS3 (r 2 Z0.258; P!0.08). Table 1 shows linear correlation coefficients for mRNA expression among the various angiogenic factors and factors involved in the regulation of angiogenesis.
Discussion
The present study demonstrated that angiogenesis is initiated very early in pregnancy, since an increase in vascular LI was first observed on day 14 of pregnancy, and several measurements of angiogenesis including CAD, CSD, and APC, and expression of several angiogenic factors increased by day 16 of pregnancy. The most dramatic increase was observed for vascular LI during days 14-20 of pregnancy, and this was maintained until day 30. This enhanced vascular cell proliferation likely allows for rapid blood vessel growth, which was reflected by the increase of CAD, CSD, and APC seen in endometrium. Thus, the time of the major increase in vascular cell proliferation corresponds to the period of maternal recognition of pregnancy, initial attachment/implantation of fetal membranes to uterine epithelium, and initiation of placental growth and development (Bowen & Burghardt 2000 , Spencer et al. 2004 , 2008 , Bazer et al. 2009a , 2009b . Numerous factors of fetal and uterine origin have been identified in the maternal recognition of pregnancy and implantation in sheep including interferon-t, glycoproteins, steroid hormones, prostaglandins, osteopontin, and growth factors and their receptors (Bowen & Burghardt 2000 , Spencer et al. 2004 , Cammas et al. 2006 , Weems et al. 2006 , Bazer et al. 2009a , 2009b . Some of these factors (e.g. FGF, HIF, prostaglandins, and osteopontin) have been recognized as factors which are involved in the regulation of angiogenesis (Reynolds & Redmer 2001 , Reynolds et al. 2002 , 2005a , 2005b , Bazer et al. 2009a , 2009b . Thus, initiation of angiogenesis seems to be directly associated with maternal recognition of pregnancy and implantation. However, further study should be undertaken to identify which factors are involved in both pregnancy recognition signaling and initiation of angiogenesis.
For humans, angiogenesis associated with extensive vascular remodeling in endometrium is initiated during the first weeks of pregnancy and is completed around 20 weeks of gestation (Huppertz & Peeters 2005 , Arroyo & Winn 2008 . Increased endometrial endothelial cell proliferation and blood vessel diameter were observed /1000 mm 2 tissue area, CND was 1.4G0.1 capillary/1000 mm 2 tissue area, CSD was 502G71 mm/1000 mm 2 tissue area, APC was 50G3 mm 2 , and area occupied by positive factor VIII staining was 1.08G0.21%/tissue area. Size of images used for image analysis was 37 867.5 mm 168 A T Grazul-Bilska and others on week 2 of pregnancy in the marmoset (Rowe et al. 2004) . In rats, a dramatic increase in endothelial cell proliferation index was observed as early as on day 3 of pregnancy; however, endothelial cell density did not change in endometrium (Goodger & Rogers 1995) . Based on our results and those presented above, it is reasonable to postulate that maternal recognition of pregnancy and implantation involves the initiation of angiogenesis manifested first by increased vascular cell proliferation followed by enhanced vascularization and expression of angiogenic factors in maternal placenta.
The pattern of blood vessel growth during early pregnancy in this study resembles the pattern from mid to late pregnancy described previously (Borowicz et al. 2007 ) except that during early pregnancy, the number of blood vessels per unit tissue area decreased perhaps reflecting the large increase in capillary size. As pregnancy progresses, both APC and number of blood vessels per tissue area increased moderately (Borowicz et al. 2007 ). Additionally, during early pregnancy, changes in the pattern of expression for mRNAs of some of angiogenic factors and/or factors involved in the regulation of angiogenesis differed (e.g. NOS3, ANGPT1, ANGPT2, and HIF1A), while some were similar (e.g. VEGF, VEGFR1, VEGFR2, TEK, and FGF2) to those reported for mid to late pregnancy (Borowicz et al. 2007) . This indicates a different role of specific angiogenic factor in the regulation of blood vessel growth and function at different stages of pregnancy in sheep. However, this subject should be further investigated.
The expression of several angiogenic factors and their receptors in endometrial tissues during early pregnancy has been evaluated for several species including humans, nonhuman primates, sheep, and cows However, information on temporal changes in the expression of selected angiogenic factors and/or factors involved in the regulation of angiogenesis in the placenta is very limited. In the present study, increases in the expression of mRNAs of receptors for VEGF, FGF2, and ANGPT receptors, and for NOS3 in maternal placenta were observed as early as on days 14-18 of pregnancy. In the nonhuman primates, endometrium/decidua, protein and/or mRNA for VEGF and/or VEGFRs were detected during early pregnancy (Ghosh et al. 2000 , Sherer & Abulafia 2001 , Wang et al. 2003 , Wei et al. 2004 , Liu et al. 2005 . However, in contrast to our results, mRNA expression for FLT1 and KDR in endometrium decreased from day 12 to 26 of pregnancy (Wang et al. 2003) in nonhuman primates. This striking difference is likely due to the major differences in the placental physiology between these two species. For cows, VEGF, FLT1, and/or KDR proteins were immunolocalized in placentomes before, around, and after the time of implantation (Pfarrer et al. 2006) . Thus, these data indicate that for several species, changes in VEGF and VEGFR expression in placenta occur very early in pregnancy, indicating that the VEGF system is involved in the regulation of angiogenesis and likely other processes during early pregnancy.
PGF, which is a member of the VEGF family, was detected at the protein and/or mRNA levels in endometrium/decidua and serum during pregnancy in several species (Ghosh et al. 2000 , Regnault et al. 2002 , Borowicz et al. 2007 , Makrydimas et al. 2008 . However, little is known about the role of PGF during early pregnancy. Nevertheless, PGF is recognized as a potential marker of pre-eclampsia in humans, and also as a regulator of placental angiogenesis (Sherer & Abulafia 2001 , Torry et al. 2003 , Baumann et al. 2007 , Moore Simas et al. 2007 . In the present study, expression of PGF mRNA in endometrium increased during early pregnancy, and this change was positively correlated with vascular LI, CAD, and APC, and with the expression of mRNAs for FLT1, KDR, ANGPT1, and NOS3. Interestingly, expression of PGF mRNA was also positively correlated with the expression of FLT1 and NOS3 in CAR tissue of estrogen-treated ovariectomized sheep . Together, these results indicate that PGF expression and function are associated with the expression/function of VEGF, ANGPT, and NOS systems in maternal placenta. In our study, expression of HIF1A mRNA in endometrium increased transiently on days 16-20 of pregnancy, which suggests a role of HIF1A during the initiation of angiogenesis. Similar results of enhanced expression of HIF1A and HIF2A mRNAs in ovine endometrium from days 14-20 of pregnancy were reported by Song et al. (2009) . In fact, it has been demonstrated that HIF1A is critical for placental development, and is involved in the regulation of placental angiogenesis through the regulation of VEGF and several other genes (Cowden Dahl et al. 2005 , Fryer & Simon 2006 , Tayade et al. 2007 , Song et al. 2009 ). Thus, growth factors and receptors from the VEGF and ANGPT family, and factors regulating them are likely involved in the initiation of angiogenesis in maternal placenta during early pregnancy.
Expression of FGF2 and FGFR2IIIc mRNA was detected in placental tissues in the present study. However, only insignificant changes in their expression during early pregnancy were observed. FGF2 and FGFR2IIIc protein was also detected in uterine tissues during early pregnancy in sheep (Reynolds et al. 2008) . In rhesus monkeys, both FGF2 and FGFR proteins were expressed in maternal placenta during early pregnancy (Wei et al. 2004 , Liu et al. 2005 . Since FGF2 and its receptors are recognized as factors regulating cell and tissue growth (Presta et al. 2005) , these factors may have a role in the initiation and regulation of angiogenesis and induce uterine cell proliferation during early pregnancy.
In the present study, expression of mRNAs for ANGPTs and their receptor TEK as well as NOS3 increased during early pregnancy. Although expression of ANGPT and NOS3 family members has been investigated in uteroplacental tissues in several species (Galan et al. 2001 , Hagen et al. 2005 , Vonnahme et al. 2005 , Ziebell et al. 2007 , limited data are available concerning NOS3 expression and function in placenta during early pregnancy. Based on the study of mouse uterine tissues during early pregnancy, Purcell et al. (1999) suggested that after implantation, NOS may play a role in tissue remodeling, immunosuppression, and vasoregulation. Furthermore, since NOS3 has been demonstrated to interact with the VEGF system, NOS3 may enhance the production and function of members of the VEGF system The P values are provided for each correlation coefficients which are statistically significant (P!0.0001-0.05) or tend (P%0.05-0.1) to be statistically significant.
170 A T Grazul-Bilska and others in placental tissues during early pregnancy (Reynolds & Redmer 2001 , Reynolds et al. 2002 , Beckman et al. 2006 . In the present study, these possible interactions are reflected by significant correlations between expression of NOS3 and members of the VEGF system (e.g. PGF, FLT1, and KDR). In addition, expression of NOS3 mRNA was correlated with the expression of the ANGPT system members (e.g. ANGPT1, ANGPT2, and TEK) indicating a possible relationship between these two systems. Since Dunk et al. (2000) demonstrated that ANGPTs are involved in the regulation of NO release by trophoblast cells, it seems reasonable to postulate that ANGPTs are also involved in the regulation of the NOS system in maternal placenta. In summary, in this study, we have described changes in vascular architecture, vascular cell proliferation, expression of factor VIII and mRNA for several angiogenic factors and factors involved in the regulation of angiogenesis, and also an association between these two processes (e.g. vascular growth and expression of angiogenic and other factors) in the maternal placenta. The patterns of changes in vascular development parallel those for the expression of several angiogenic and other factors indicating complex regulation of angiogenic processes which regulate uterine and placental blood flow (Reynolds et al. 1984 , Reynolds & Redmer 1995 . Thus, angiogenesis is crucial in developing and building the placental life line between the maternal and fetal systems, and when affected, fetal growth and development are also affected (Carter & Charnock-Jones 2001 , Wulff et al. 2003 , Arroyo & Winn 2008 , Fraser & Duncan 2009 . In fact, abnormalities of placental angiogenesis and expression of angiogenic factors are associated with a variety of compromised pregnancies, including those resulting from environmental stress, maternal iron deficiency, pre-eclampsia, gestational diabetes, cigarette smoking, application of assisted technologies, and other factors , 2010 , Arnold et al. 2008 , Stillerman et al. 2008 . Therefore, results from our study may help to identify factors that can be used therapeutically to restore normal placental vascular function and blood flow to rescue compromised pregnancies, and also to determine the causes and consequences of pregnancy failures in compromised pregnancies. In addition, these results provide valuable references for comparison of the patterns of vascularization and expression of angiogenic factors, and timing of angiogenesis in compromised and normal pregnancies.
Materials and Methods

Animals and tissue collection
The Institutional Animal Care and Use Committee at NDSU approved all animal procedures in this study. Gravid uteri were obtained from crossbred western range (primarily Rambouillet, Targhee, and Columbia crossbreeds) ewes (nZ6-8 per day) on days 14, 16, 18, 20, 22, 24, 26, 28 , and 30 after mating (day of matingZday 0), and also from mid-luteal, NP (day 10 after estrus; nZ8) control ewes. For immunohistochemical staining, at tissue collection, specimen pins were inserted completely through the uterus and fetal membranes at the level of the external intercornual bifurcation to maintain specimen morphology; cross sections of the entire gravid uterus (0.5 cm thick) were obtained using a Stadie-Riggs microtome blade, immersion-fixed in Carnoy's solution, and embedded in paraffin. For total cellular (tc) RNA extraction, CAR tissues were cut from the area of the uterus closest to the embryo and uterine body, snap-frozen, and stored at K70 8C.
Histochemistry and immunohistochemistry
Histochemical and immunohistochemical procedures were described previously (Borowicz et al. 2007 ). Briefly, paraffin-embedded tissues were sectioned at 5 mm, mounted onto glass slides, rinsed several times in PBS containing Triton-X100 (0.3%, v/v), and treated for 20 min with blocking buffer (PBS containing normal goat serum (2%, vol/ vol)). The tissue sections were then incubated with specific primary antibody for PCNA (1:500 dilution; monoclonal mouse; Zymed, San Francisco, CA, USA) or factor VIII (1:100; rabbit polyclonal, Sigma) overnight at 4 8C. Primary PCNA or factor VIII were detected using biotin-labeled secondary anti-mouse or anti-rabbit antibodies respectively and the ABC method (Vector Laboratories, Burlingame, CA, USA). For PCNA staining, the sections were then counterstained with H plus PAS. Control sections were incubated with normal mouse or rabbit serum in place of PCNA or factor VIII primary antibody respectively.
Image analysis
Image analysis was performed as previously described in detail (Borowicz et al. 2007 , Grazul-Bilska et al. 2009 ). Images of randomly chosen areas of ICAR and CAR (5-10 per uterine section/sheep; 0.025 mm 2 per field) stained for PCNA or factor VIII were taken at 600! (PCNA) or 400! (factor VIII) magnification, using an Eclipse E600 Nikon microscope and digital camera. Vascular LI (proportion of proliferating cells within blood vessels), vascularity, and relative expression of factor VIII were determined using computerized image analysis (Image-Pro Plus, version 5.0; Media Cybernatics, Houston, TX, USA). The following vascularity measurements were determined for endometrial CAR and ICAR: the number of proliferating nuclei along with the total number of nuclei within blood vessels per tissue area to determine vascular LI, CAD, CND, CSD, APC, and the percentage of the total tissue area that exhibited positive staining for factor VIII.
Quantitative real-time RT-PCR
All procedures and sequences of Taqman probes and primers for determining the expression of mRNA for angiogenic factors in ovine CAR tissues by RT-PCR have been reported previously (Redmer et al. 2005 . Briefly, snap-frozen CAR tissues were homogenized in Angiogenesis during maternal placental development Tri-Reagent (Molecular Research Inc., Cincinnati, OH, USA) according to the manufacturer's specifications. The quality and quantity of tcRNA were determined via capillary electrophoresis using the Agilent 2100 Bioanalyzer (Agilent Technologies, Wilmington, DE, USA). Real-time RT-PCR reagents, probes, and primers were purchased from and used as recommended by Applied Biosystems (Foster City, CA, USA). For each sample, 30 ng of tcRNA were reverse transcribed in triplicate 20-ml reactions using random hexamers. The ABI PRISM 7000 was used for the detection of sequences amplified at 60 8C typically for 40 or 45 cycles (Applied Biosystems). Expression of each angiogenic factor was normalized to the expression of 18S in a multiplex reaction using the human 18S pre-developed assay reagent (PDAR) from Applied Biosystems. The PDAR solution, which is primer limited and contains a VIClabeled probe, was further adjusted using one-fourth of the normal amount, so that it would not interfere with amplification of the FAM-labeled gene of interest. The multiplex reaction was also used to generate standard curves for quantification of 18S, and the gene of interest based on dilutions of the cDNA generated from tcRNA collected from pooled placentomal tissues collected on day 130 of pregnancy.
Statistical analysis
Data were analyzed using the general linear model procedure of SAS, with the main effect of day of pregnancy (SAS Institute 2008) , and are presented as meansGS.E.M. Data are expressed as a fold change compared with the NP control arbitrarily set as 1. When the F-test was significant (P!0.05), differences between specific means were evaluated using the least significant differences test (Kirk 1982) . Simple linear correlations between specific variables were calculated using PROC CORR of SAS.
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